CVE-2026-31070
Published: 19 May 2026
Summary
CVE-2026-31070 is a critical-severity Improper Privilege Management (CWE-269) vulnerability. Its CVSS base score is 9.8 (Critical).
Operationally, ranked at the 11.3th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.
Threat & Defense Details
Likely Mitigating ControlsAI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Policy addresses roles, responsibilities, and privilege management to prevent improper privilege assignments.
Access supervision ensures privileges are assigned and managed without improper escalation or retention.
Assigning group/role memberships and access authorizations (privileges) while reviewing accounts addresses improper privilege management.
Enforces proper privilege management by requiring all decisions through the verified reference monitor.
By mandating division of duties across roles, the control enforces proper privilege management and prevents a single entity from controlling an entire sensitive process.
Implements core proper privilege management by restricting to only required rights.
Policy requires training on privilege management and least privilege, making it harder to exploit improper privilege management weaknesses.
Training covers proper privilege management practices, making incorrect privilege assignments less likely.
NVD Description
The LalanaChami Pharmacy Management System (commit 5c3d028) allows unauthenticated remote attackers to escalate privileges by self-assigning an administrative role during registration. The /api/user/signup endpoint fails to validate the role parameter in the request body
Deeper analysisAI
Automated synthesis unavailable for this CVE.
Details
- CWE(s)